The third quarter earnings season is ongoing with key companies like Coal India, Tata Steel, and Indian Oil set to announce ...

The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

Syngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects ...

Here's a list of buy/sell recommendations for today from three analysts: Ankush Bajaj, Raja Venkatraman, and MarketSmith ...

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...

The US Food and Drug Administration (FDA) has classified Biocon Biologics’ insulin facilities in Johor Bahru, Malaysia, as Voluntary Action Indicated (VAI). The US health regulator conducted a ...

“Biocon stock price has broken out from the ... flies to Saudi Arabia in style Eating how many almonds a day is healthy History or Mythology: 7 Proofs the Mahabharata Was Real New Expressway ...

BRIDGEWATER, N.J., and BENGALURU, India, Jan. 9, 2025 /PRNewswire/ --Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: ...

Biocon share price history Biocon shares have gained about 2 per cent in the last 5 days. The scrip has surged nearly 33 per cent in the past year. The market capitalisation of Biocon is Rs 44,692.34 ...

In 2010, Jagdeep Singh founded QuantumScape, a company focusing on innovations in battery technology in EVs. Image courtesy: X/@@QuantumScapeCo Not Sundar Pichai or Satya Nadella, but Jagdeep Singh ...